XML 16 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Earnings - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]        
NET SALES $ 19,776 $ 20,195 $ 63,395 $ 63,507
Cost of products sold 9,694 9,855 30,533 30,500
Selling, general and administrative expense 5,524 5,880 16,765 17,006
Indefinite-lived intangible asset impairment charge 0 0 0 1,341
OPERATING INCOME 4,558 4,460 16,096 14,660
Interest expense (217) (233) (695) (705)
Interest income 111 104 365 366
Other non-operating income/(expense), net 210 260 (120) 570
EARNINGS BEFORE INCOME TAXES 4,661 4,592 15,646 14,891
Income taxes 868 812 3,207 3,061
NET EARNINGS 3,793 3,781 12,439 11,830
Less: Net earnings attributable to noncontrolling interests 23 27 80 88
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 3,769 $ 3,754 $ 12,359 $ 11,742
NET EARNINGS PER COMMON SHARE        
Basic (in dollars per share) [1] $ 1.58 $ 1.56 $ 5.16 $ 4.89
Diluted (in dollars per share) [1] $ 1.54 $ 1.52 $ 5.03 $ 4.75
[1] Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.